These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25441457)

  • 21. The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment.
    Coulthard SA; Matheson EC; Hall AG; Hogarth LA
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1385-91. PubMed ID: 15571264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between single nucleotide polymorphisms in thiopurine methyltransferase gene and tolerance to thiopurines in acute leukemia].
    Ma XL; Zhu P; Wu MY; Li ZG; Hu YM
    Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):929-33. PubMed ID: 14723818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations.
    Maillard M; Nishii R; Yang W; Hoshitsuki K; Chepyala D; Lee SHR; Nguyen JQ; Relling MV; Crews KR; Leggas M; Singh M; Suang JLY; Yeoh AEJ; Jeha S; Inaba H; Pui CH; Karol SE; Trehan A; Bhatia P; Antillon Klussmann FG; Bhojwani D; Haidar CE; Yang JJ
    J Natl Cancer Inst; 2024 May; 116(5):702-710. PubMed ID: 38230823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects.
    Brouwer C; De Abreu RA; Keizer-Garritsen JJ; Lambooy LH; Ament K; ter Riet PG; van Wering ER; Trijbels FJ; Veerman AJ; Hoogerbrugge PM; Bökkerink JP
    Eur J Cancer; 2005 Mar; 41(4):613-23. PubMed ID: 15737567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiopurine methyltransferase pharmacogenetics: alternative molecular diagnosis and preliminary data from Northern Portugal.
    Alves S; Prata MJ; Ferreira F; Amorim A
    Pharmacogenetics; 1999 Apr; 9(2):257-61. PubMed ID: 10376773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of thiopurine S-methyltransferase genetic variation in Thai children with acute leukemia.
    Hongeng S; Sasanakul W; Chuansumrit A; Pakakasama S; Chattananon A; Hathirat P
    Med Pediatr Oncol; 2000 Oct; 35(4):410-4. PubMed ID: 11025471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe.
    van den Akker-van Marle ME; Gurwitz D; Detmar SB; Enzing CM; Hopkins MM; Gutierrez de Mesa E; Ibarreta D
    Pharmacogenomics; 2006 Jul; 7(5):783-92. PubMed ID: 16886902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thiopurine methyltransferase polymorphisms in a multiracial asian population and children with acute lymphoblastic leukemia.
    Kham SK; Tan PL; Tay AH; Heng CK; Yeoh AE; Quah TC
    J Pediatr Hematol Oncol; 2002; 24(5):353-9. PubMed ID: 12142782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia.
    Hawwa AF; Collier PS; Millership JS; McCarthy A; Dempsey S; Cairns C; McElnay JC
    Br J Clin Pharmacol; 2008 Dec; 66(6):826-37. PubMed ID: 18823306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of TPMT activity and TGNs level detection for individualizing 6-mercaptopurine chemotherapy].
    Gu LJ; Ye QD; Liang AB; Zhao JC; Xue HL; Tang YN; Chen J; Ye YC
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):18-21. PubMed ID: 12679004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts.
    Milek M; Karas Kuzelicki N; Smid A; Mlinaric-Rascan I
    Biochem Pharmacol; 2009 Jun; 77(12):1845-53. PubMed ID: 19428339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine.
    Desire S; Balasubramanian P; Bajel A; George B; Viswabandya A; Mathews V; Srivastava A; Chandy M
    Med Oncol; 2010 Dec; 27(4):1046-9. PubMed ID: 19830600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status.
    Stocco G; Crews KR; Evans WE
    Expert Opin Drug Saf; 2010 Jan; 9(1):23-37. PubMed ID: 20021291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacogenomics of thiopurine S-methyltransferase.
    Zhou S
    Curr Clin Pharmacol; 2006 Jan; 1(1):119-28. PubMed ID: 18666383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols.
    Stanulla M; Schaeffeler E; Möricke A; Coulthard SA; Cario G; Schrauder A; Kaatsch P; Dördelmann M; Welte K; Zimmermann M; Reiter A; Eichelbaum M; Riehm H; Schrappe M; Schwab M
    Blood; 2009 Aug; 114(7):1314-8. PubMed ID: 19535798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of molecular and enzyme-based assays for the detection of thiopurine methyltransferase mutations.
    Coulthard SA; Rabello C; Robson J; Howell C; Minto L; Middleton PG; Gandhi MK; Jackson G; McLelland J; O'Brien H; Smith S; Reid MM; Pearson AD; Hall AG
    Br J Haematol; 2000 Sep; 110(3):599-604. PubMed ID: 10997970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thiopurine methyltransferase deficiency in childhood lymphoblastic leukaemia: 6-mercaptopurine dosage strategies.
    Lennard L; Lewis IJ; Michelagnoli M; Lilleyman JS
    Med Pediatr Oncol; 1997 Oct; 29(4):252-5. PubMed ID: 9251729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans.
    Loennechen T; Yates CR; Fessing MY; Relling MV; Krynetski EY; Evans WE
    Clin Pharmacol Ther; 1998 Jul; 64(1):46-51. PubMed ID: 9695718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An audit of thiopurine methyltransferase genotyping and phenotyping before intended azathioprine treatment for dermatological conditions.
    Vestergaard T; Bygum A
    Clin Exp Dermatol; 2010 Mar; 35(2):140-4. PubMed ID: 19663853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiopurine S-methyltransferase pharmacogenetics: genotype to phenotype correlation in the Slovenian population.
    Milek M; Murn J; Jaksic Z; Lukac Bajalo J; Jazbec J; Mlinaric Rascan I
    Pharmacology; 2006; 77(3):105-14. PubMed ID: 16691038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.